The treatment of hematological malignancies is rapidly progressing, involving new therapies through a greater understanding of biologic mutations. The CARE Hematology Faculty met at the American Society of Clinical Oncology (ASCO) conference in Chicago, Illinois on May 31–June 4, 2013 to discuss news and developments in hematological oncology.
Report content and visuals that follow are a reprise of the presentations by Dr. John Kuruvilla and Dr. Rob Laister during the CORE (Canadian Oncology Resident Education) program and CARE Hematology Working Group meeting at ASCO 2013, framed from a Canadian perspective and augmented with key abstracts and plenary session content from the conference. Additional content and abstracts have been included from Princess Margaret Cancer Centre’s Multiple Myeloma Day (June 6, 2013; Toronto, Ontario), the European Hematology Association’s (EHA) 18th annual conference (June 13–16, 2013; Stockholm, Sweden) and the 12th annual International Conference on Malignant Lymphoma (ICML) (June 19–22, 2013; Lugano, Switzerland) showcasing evolving stories in this field.
Below is a link to the full Report: